🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christina L. Gersch

ORCID: 0000-0001-7381-6703
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Genetic Variation in Charcot–Marie–Tooth Genes Contributes to Sensitivity to Paclitaxel-Induced Peripheral Neuropathy”.

Genetic Variation in Charcot–Marie–Tooth Genes Contributes to Sensitivity to Paclitaxel-Induced Peripheral Neuropathy

Pharmacogenomics(2020)10.2217/pgs-2020-0053
N/A
0DataRank · unranked
14 citations

Fang Fang, Kelley M. Kidwell, Kiran Vangipuram, Lauren A. Marcath, Christina L. Gersch +7 more

Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer

Frontiers in Genetics(2021)10.3389/fgene.2021.662734
N/A
0DataRank · unranked
14 citations

Karen L. Smith, Yuhua Zong, Christina L. Gersch, Andrea M. Pesch, Jennifer Lehman +6 more

Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms

Research Square(2022)10.21203/rs.3.rs-1315678/v1
N/A
0DataRank · unranked
5 citations

Julie A. Douglas, Robert M. Miller, Kelley M. Kidwell, Christina L. Gersch, Zeruesenay Desta +7 more

Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01521
N/A
0DataRank · unranked
21 citations

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, Dimin Wu, Jianfeng Lü +18 more

Correction to “Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer”

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00592
N/A
0DataRank · unranked
1 citations

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, Dimin Wu, Jianfeng Lü +18 more